7 results
10-K
2023 FY
APGE
Apogee Therapeutics, Inc.
5 Mar 24
Annual report
6:15am
and implemented by the FDA. In July 2018, the FDA announced an action plan to encourage the development and efficient review of biosimilars, including … to enter into a resolution agreement and corrective action plan with HHS to settle allegations of HIPAA non-compliance. A covered entity or business
DRS
APGE
Apogee Therapeutics, Inc.
9 Feb 24
Draft registration statement
12:00am
by the FDA. In July 2018, the FDA announced an action plan to encourage the development and efficient review of biosimilars, including … to enter into a resolution agreement and corrective action plan with HHS to settle allegations of HIPAA non- compliance. A covered entity or business
424B4
APGE
Apogee Therapeutics, Inc.
17 Jul 23
Prospectus supplement with pricing info
4:08pm
an action plan to encourage the development and efficient review of biosimilars, including the establishment of a new office within the agency … obligations if required to enter into a resolution agreement and corrective action plan with HHS to settle allegations of HIPAA non-compliance. Further
S-1
APGE
Apogee Therapeutics, Inc.
22 Jun 23
IPO registration
4:19pm
.
The BPCIA is complex and continues to be interpreted and implemented by the FDA. In July 2018, the FDA announced an action plan to encourage … into a resolution agreement and corrective action plan with HHS to settle allegations of HIPAA non-compliance. Further, entities that knowingly obtain
DRS/A
lb6uxyo
5 Jun 23
Draft registration statement (amended)
12:00am
DRS
xd5guu 08koh1d09
28 Apr 23
Draft registration statement
12:00am
- Prev
- 1
- Next